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Stability indicating UFLC method
Topical delivery systems
a b s t r a c t
There is a growing interest in the pharmaceutical ﬁeld concerning isoﬂavones topical delivery systems,
especially with regard to their skin care properties and antiherpetic activity. In this context, the present
work describes an ultra-fast liquid chromatography method (UFLC) for determining daidzein, glycitein,
and genistein in different matrices during the development of topical systems containing isoﬂavone
aglycones (IA) obtained from soybeans. The method showed to be speciﬁc, precise, accurate, and linear
(0.1 to 5 mg mL1) for IA determination in soybean acid extract, IA-rich fraction obtained after the
puriﬁcation process, IA loaded-nanoemulsions, and topical hydrogel, as well as for permeation/retention
assays in porcine skin and porcine esophageal mucosa. The matrix effect was determined for all complex
matrices, demonstrating low effect during the analysis. The stability indicating UFLC method was
veriﬁed by submitting IA to acidic, alkaline, oxidative, and thermal stress conditions, and no interference
of degradation products was detected during analysis. Mass spectrometry was performed to show the
main compounds produced after acid hydrolysis of soybeans, as well as suggest the main degradation
products formed after stress conditions. Besides the IA, hydroxymethylfurfural and ethoxymethylfurfural
were produced and identiﬁed after acid hydrolysis of the soybean extract and well separated by the UFLC
method. The method’s robustness was conﬁrmed using the Plackett-Burman experimental design.
Therefore, the new method affords fast IA analysis during routine processes, extract puriﬁcation,
products development, and bioanalytical assays.
& 2014 Elsevier B.V. All rights reserved.
1. Introduction
The use of soybeans is of interest from scientiﬁc and economic
points of view, basically due to the presence of isoﬂavones [1].
These compounds have demonstrated beneﬁcial health effects,
especially for preventing heart disease, osteoporosis, cancer, and
diabetes [2], plus reducing climacteric symptoms in menopausal
and postmenopausal women [3]. Moreover, isoﬂavones act against
acute virus infections [4], and have many beneﬁcial effects on the
skin [5,6], demonstrating a growing interest on their topical use in
the pharmaceutical and cosmetics ﬁeld.
In general, isoﬂavones are incorporated into topical products in
their glycoside forms [7]. In some cases, this may limit the
biological action of these conjugated forms due to the low
possibility of penetration through different skin layers or mucosa
tissues [7]. Therefore, to get the isoﬂavones’ desired effects, their
aglycone forms such as daidzein, glycitein, and genistein, should
preferably be used [7,8]. However, it is important to highlight that
the isoﬂavone aglycones (IA) are less hydrosoluble than the
conjugated forms, and this may limit their incorporation into
traditional topical delivery systems [7]. To allow better use of IA
in formulations and enhance their penetration, some alternative
technologies have been studied, such as nanoemulsions [9-12].
During products development, routine analysis, or biological
assays, it is essential to use an adequate method for quantiﬁcation
of the compounds of interest. In this way, a number of analytical
methods has been reported for isoﬂavones analysis [13,14].
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Nevertheless, high-pressure liquid chromatography (HPLC) with
ultraviolet-visible (UV–vis) detector is, undoubtedly, the method
of choice applied in this ﬁeld [13,14]. Although the HPLC methods
have some advantages when it comes to analyzing isoﬂavones in
terms of speciﬁcity, sensitivity, and straightforward operation,
they require a relatively long period of time, normally from
20 min [15] to 65 min [16]. To overcome this lengthy amount of
time, the use of high-throughput liquid chromatography technol-
ogies has been reported in the last decade for isoﬂavone analysis,
reducing the chromatographic time to less than 10 min [17–21].
These techniques allow the use of short columns, packed with o3
μm particles, supporting elevated pressures, thus reducing the
analysis time, solvent consumption, and, consequently, the envir-
onmental impact [22].
Among the high-throughput methods reported in the literature
for isoﬂavones analysis, ultra-performance liquid chromatography
(UPLC) and ultra-fast liquid chromatography (UFLC) are cited for
their determination in soybeans cultivars [21], phytoestrogen-rich
plants [17,23,24], soy bits [17], soymilk [25], texturized soy protein
[20], and soy-based nutritional supplements [26]. However, none
of them have reported the use of UFLC or UPLC for pharmaceutical
or cosmetic formulation containing isoﬂavones and for permea-
tion/retention studies of these compounds on skin or mucosa
tissues.
Recently, our research group reported a stability-indicating
HPLC method for routine analysis of IA present in soybeans after
acid hydrolysis, as well as in nanoemulsions containing the extract
[27]. The method has been reported as a new approach for
isoﬂavones analysis, since it can be used to indicate the stability
of these compounds in different stress conditions, but it has one
big drawback: the total analysis time is quite long (30 min) as
compared with the new scenario of chromatographic methods
[17,20–26]. Therefore, the development of a fast and reliable
method to analyze IA in complex biological matrices, even in the
presence of their degradation products, becomes a new challenge
in the current chromatographic systems for isoﬂavones analysis.
In this context, the aim of this work was the development and
validation of a stability-indicating UFLC method for the determi-
nation of daidzein (DAID), glycitein (GLY), and genistein (GEN)
applied to different assays, such as routine analysis of soybeans,
monitoring the puriﬁcation process, development of nanoemul-
sions and hydrogels containing IA, and their permeation/retention
assay in porcine esophageal mucosa and porcine skin. The matrix
effect for all of these applications was assessed to demonstrate the
versatility and reliability of the UFLC method for IA analysis. Mass
spectrometry analysis was performed to show the main products
formed after acid hydrolysis of the soybeans, demonstrates the
method speciﬁcity, and suggests the main degradation products
formed after stress conditions. In addition, the most complex
matrix used in this study (soybean acid extract) was also analyzed
by a previously validated HPLC method to show the advantages in
time and resolution of the new method being proposed.
2. Material and methods
2.1. Chemicals and materials
Isoﬂavone standards, daidzein, glycitein, and genistein (Z95%,
Z98%, and Z98% of purity, respectively) were purchased from
Cayman Chemical Company (Ann Arbor, MI, USA). Methanol and
acetonitrile liquid chromatography grade were obtained from
Merck (Darmstadt, Germany). Egg-lecithin (Lipoid E-80s) and
medium chain triglycerides (MCT) were purchased from Lipoid
GmbH (Ludwigshafen, Germany). Ultrapure water was obtained
from a Milli-Q apparatus (Millipore, Billerica, USA). The soybeans
(cultivar BRS 262) were obtained from Empresa Brasileira de
Pesquisa Agropecuária (EMBRAPA), kindly donated by SEMEL seeds
(São Paulo, Brazil). Porcine ears and porcine esophageal mucosa
were obtained from a local slaughterhouse.
2.2. Apparatus and analytical conditions
2.2.1. UFLC analysis
The UFLC analysis was performed on a Shimadzu Prominence
system device coupled to a photodiode array (PDA) detection and
an automatic injector controlled by LC-Solution Multi-PDA soft-
ware (Kyoto, Japan). The stationary phase was a Shim-pack XR ODS
column (Shimadzu, 1002.0 mm i.d.; particle size, 2.2 mm)
guarded by an in-line pre-column ﬁlter Ultra KrudKatcher (Phe-
nomenex, USA). The mobile phase consisted of (A) triﬂuoroacetic
acid 0.1% (v/v) and (B) acetonitrile. The gradient elution was 20–
25% B (0–2 min), 25–30% B (2–3 min), 30–35% B (3–4 min), and
35-20% B (4–6 min). The column was re-equilibrated with 20% B
for 2 min before the next analysis. The ﬂow rate was a gradient of
0.35 mL min1 (0–1.5 min), 0.35–0.5 mL min1 (1.5–2 min),
0.5 mL min1 (2–3 min), 0.5-0.35 mL min1 (3-4 min), and
0.35 mL min1 up to 8 min. The wavelength was adjusted to
260 nm, injection volume of 3 mL, and the analysis was carried
out at 55 1C.
2.2.2. HPLC analysis
The HPLC analysis was carried out as described by Yatsu et al.
[27], and was performed on a Shimadzu LC-20AT system (Kyoto,
Japan), coupled to PDA detector controlled by LC-Solution Multi-
PDA software. The stationary phase was a Synergi-Fusion-RP
column (Phenomenex, 1504.6 mm i.d.; particle size, 4.0 mm),
protected with a C-18 guard column. The mobile phase consisted
of (A) acidiﬁed Milli-Q water (0.01% triﬂuoroacetic acid) and
(B) acidiﬁed acetonitrile (0.1% triﬂuoroacetic acid). The gradient
elution was: 20–25% B (0–10 min), 25–30% B (10–15 min), 30–35%
B (15–23 min), 35% B (23–26 min), and 35-20% B (26–30 min),
maintained at a ﬂow rate of 1.0 mL min1. The wavelength was
adjusted to 260 nm, injection volume of 10 mL, and the analysis
was carried out at 40 1C.
2.2.3. Mass spectrometry (MS)
The MS analysis was performed on a Micromass-LCT Premier
Time of Flight (TOF) mass spectrometer (Waters, MA, USA) with an
electrospray interface and coupled with an Acquity UPLC system
(Waters, MA, USA). The chromatography parameters were similar
to those of the UFLC analysis; nevertheless TFA was changed for
acid formic. The ESI conditions were: capillary voltage 3000 V,
sample cone 30 V, source temperature 120 1C, desolvation tem-
perature of 300 1C, cone gas ﬂow 70 L.h1 and desolvation gas
ﬂow of 350 L/h. Detection was performed in positive ion mode
(ESIþ) in the m/z range 50–300. Software used to control spectro-
meter, data acquisition and data processing was MassLynx (v 4.1).
The molecular ions [MþH]þ monitored during the analysis were
m/z 255, 285, and 271, correspondingly of DAID, GLY, and GEN,
respectively. The criteria for fragments selection were intensity
and speciﬁcity being selected three fragments for compound in
accordance with Wu et al. [28].
2.3. Solutions
2.3.1. Stock and reference solutions
A stock solution (30 mg mL1) of DAID, GLY, and GEN was
prepared in methanol by weighing approximately 3.0 mg of the
compounds into a 100 mL calibrated volumetric ﬂask and diluting
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to volume. The reference solutions were prepared by the stock
solution dilution with acetonitrile 50% (v/v).
2.3.2. Matrices solutions
2.3.2.1. Soybean acid extract (SAE). Soybeans were previously
grinded and defatted by exhaustive extraction with n-hexane in
a Soxhlet apparatus. The extraction of isoﬂavones from defatted
soybean material was performed in a Soxhlet using 80% ethanol at
the temperature of 70–80 1C for 4 h (1:10, w/v). Afterward, 1.3 M
hydrochloric acid (HCl) was added and the mixture was heated at
temperature of 80 1C for 2 h under reﬂux. An adequate aliquot was
diluted in acetonitrile 50% (v/v), ﬁltered by membrane of 0.22 mm
and analyzed.
2.3.2.2. Isoﬂavone aglycones-rich fraction. To obtain the isoﬂavone
aglycones-rich fraction (IAF), the soybean acid extract was
evaporated under reduced pressure to remove ethanol, leaving
only an aqueous phase. Liquid-liquid partition with salting-out
procedure was performed adding 20% (w/v) potassium chloride
into the aqueous phase. The mixture was partitioned with ethyl
acetate and washed with water three times to neutralize the
partitioned fraction, that was subsequently evaporated under
reduced pressure, and subjected to silica gel column. The ethyl
acetate fraction was eluted successively with a gradient system
with n-hexane: methylene chloride: ethyl acetate of increasing
polarity. Six new fractions were collected, chloroform was added
on fraction 4 and the isoﬂavone aglycones precipitated. The
residue was ﬁltrated, dried, and resuspended in methanol. An
adequate aliquot was diluted in acetonitrile 50% (v/v), ﬁltered by
membrane of 0.22 mm and analyzed.
2.3.2.3. Nanoemulsions and hydrogels. Blank nanoemulsions (NEB)
or IAF loaded-nanoemulsions (NEIAF) were composed with
absence or presence of 0.1% (w/w) of IAF. The other compounds
of formulations were medium chain triglycerides 8.0% (w/w), egg
lecithin 2.0% (w/w), polysorbate 80 1.0% (w/w) and water up to
100%. The formulations were obtained by means of spontaneous
emulsiﬁcation procedure as ﬁrstly described by Yatsu et al. [27].
An adequate aliquot was diluted in acetonitrile 50% (v/v), ﬁltered
by membrane of 0.22 mm, and analyzed.
The hydrogels containing NEB or NEIAF were prepared incorpor-
ating the nanoemulsions into carbomer-hydrogel at a ﬁnal con-
centration of 0.5% [11]. For this, Carbopol 940s was dispersed in
the nanoemulsion and the mixture was stirred at room tempera-
ture and neutralized with triethanolamine to give a hydrogel with
a pH of approximately 7.0. An adequate aliquot was diluted in
acetonitrile 50% (v/v), ﬁltered by membrane of 0.22 mm, and
analyzed.
2.3.2.4. Porcine skin layers and esophageal mucosa. Full thickness
skin was excised from the outer region of the porcine ear. After the
removal of subcutaneous fat, the skin was cut into circle pieces,
and the separation of stratum corneum was made by the tape
stripping process. The ﬁrst stripped tape was discarded, while the
following 14 tapes were placed in test tubes and used for the
stratum corneum analysis. The remaining layer (epidermis/
dermis) was reduced to tiny pieces and placed in different test
tubes. To extract the IA from skin layers, 5 mL of methanol were
added and the samples were maintained in an ultrasound bath for
30 min, as previously reported by Vargas et al. [12].
The porcine esophageal mucosa was separated from the mus-
cular layer by cutting the loose connective ﬁbers with a scalpel.
The remaining mucosa was then perforated into tiny pieces, and
placed in test tubes. For extraction procedure, 5 mL of methanol
were added on the tubes and the samples were maintained in an
ultrasound bath for 30 min. An adequate aliquot was ﬁltered by
membrane of 0.22 mm and analyzed.
2.3.2.5. Receptor ﬂuid for permeation studies. The chosen solution
to be the receptor ﬂuid for the permeation/retentions studies was
30% ethanol in phosphate buffer pH 7.4, as reported by Vargas
et al. [12]. An adequate aliquot was ﬁltered by membrane of
0.22 mm and analyzed.
2.4. Validation of UFLC method
The developed method was validated according to the ofﬁcial
guidelines. For pharmaceutical products (nanoemulsions and
hydrogel) it was used the ICH speciﬁcations [29], while for
biotechnological products (derivative from soybeans) and biologi-
cal matrices (skin layers and mucosa tissue) it was used the FDA
and EMEA recommendations [30,31]. The results were analyzed by
Student's t test and analysis of variance (ANOVA) using a sig-
niﬁcance level of α¼0.05.
2.4.1. Assessment of the matrix effect
The analyses of matrix effects (ME) were performed as reported by
Watanabe et al. [32] and Yatsu et al. [27]. The slopes obtained in
standard curves of IA standards diluted in the mobile phase were
compared with the slopes obtained in standard curves of IA-spiked in
each matrix. The studied matrices were SAE, IAF, NEB, H-NEB, porcine
epidermis/dermis skin layers (P.E/D), porcine stratum corneum layer
after tape stripping method (P.SC), porcine esophageal mucosa (P.EM)
and receptor ﬂuid (RF). Three standard curves were obtained, in three
consecutive days, by plotting the peak area versus the concentration of
the isoﬂavone aglycone standards (0.1, 1.0, 2.0, 4.0, 5.0 mgmL1) in
acetonitrile 50% (v/v) and in the matrices solutions. Five replicates
were analyzed for each concentration level.
The matrix effect was calculated based on the following
equation: ME%¼100 x [1 – (Sm/Ss)], where Sm¼slopes of the
standard curves of the isoﬂavone standards in the mobile phase
and Ss¼slopes of the standard curves of the isoﬂavone standards
in the matrix.
2.4.2. Speciﬁcity
The interference of the matrix composition was determined by
the injection of samples containing only the matrices, and samples
containing matrices spiked with DAID, GLY and GEN at the
concentrations of 2 mg mL1 each one. The IA present in the
different matrices were identiﬁed based on their UV spectra
between 200 and 400 nm, their electrospray ionization (ESIþ)
mass spectra, and their retention times, with respect to the
reference materials. The stock solutions of standards were also
submitted to a forced degradation as reported by Yatsu et al. [27].
Hydrochloric acid (HCl) was added to the standard solutions to
achieve the ﬁnal concentration of 0.5 M to verify the acid hydro-
lysis. Sodium hydroxide (NaOH) was added to the standard
solutions to achieve the ﬁnal concentration of 0.5 M to verify the
basic hydrolysis. After a pre-determined period of time, both stress
solutions were neutralized with base and acid, respectively. The
oxidative degradation was induced by storing the sample solutions
in 30% hydrogen peroxide (H2O2). All these solutions were kept in
25 1C and 60 1C and protected from light to prevent the inter-
ference of photolytic degradation. After pre-determined times, the
samples were diluted in mobile phase and analyzed using a PDA
detector determining the peak purity of isoﬂavones and MS
analysis was also performed for the degradation peaks obtained.
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2.4.3. Linearity, precision, and accuracy
The linearity of the method for each matrix was evaluated by
regression analysis using the least square method. Three standard
curves were obtained, in three consecutive days, by plotting the
peak area versus the concentration of the isoﬂavone aglycones
standards (0.1, 2.0, 4.0, 6.0, 8.0, and 10.0 mg mL1) in acetonitrile
50% (v/v) and (0.1, 1.0, 2.0, 3.0, 4.0, and 5.0 mg mL1) in matrices.
Each concentration level was analyzed in six replicates. The limit
of detection (LOD) and the limit of quantitation (LOQ) of the
method were calculated based on the standard deviation of the
intercept and on the slope of the standard curves.
The intra-day precision (repeatability) was determined by
analyzing IA at three levels (0.1, 2.0, 4.0 mg mL1) in the presence
of matrices, and with six determinations per concentration, during
the same day under the same experimental conditions. Inter-day
precision (intermediate precision) values were obtained by assay-
ing IA samples of the same concentration levels on three different
days. The standard deviation and the relative standard deviation
(RSD) were calculated for each level.
The accuracy was evaluated by adding known amounts of IA
standards at three different concentration levels (0.1, 2.0, 4.0 mgmL1)
to the post extraction matrices. At each level, samples were prepared
in six replicates and analyzed. The accuracy was evaluated as the
standardized correlation between the measured value and the theo-
retical value, as follows: RE%¼[(mean calculated concentration –
theoretical value)/theoretical value] x 100.
2.4.4. Robustness
The robustness in each matrix was investigated by the Plackett-
Burman design. The factors, analyzed in low levels (1) and high
levels (þ1), were: column oven temperature (53; 57 1C), initial
organic composition (19; 21%), initial ﬂow rate (0.34; 0.36
mL min1), and TFA concentration (0.08; 0.12%). The four factors
selected were tested with eight experiments designed in accor-
dance with Heyden et al. [33]. The responses evaluated were the
percentages of IA in the matrices obtained in relation to the
standard solutions. After the calculation of the effects for each
parameter (by the sums of the responses of the positive and
negative levels), the statistical interpretation (t-test) allowed
determination of the similarity or difference of the results. The
DAID, GLY, and GEN standards and the samples were analyzed
under identical experimental conditions, and for this reason no
additional experiments were necessary. A half-normal probability
plot for the effects in combination with the dummy factors was
used to estimate the error and identify signiﬁcant effects.
2.4.5. Recovery of IA after extraction from porcine skin and mucosa
Before the extraction procedure of porcine skin layers or
mucosa, the matrices were spiked with isoﬂavone aglycones
leading a theoretical concentration of 0.1, 2, and 4 mg mL1.
Methanol was added in each matrix test tube, and the samples
were maintained in an ultrasound bath for 30 min, ﬁltered
through a 0.22 μm membrane and analyzed by UFLC.
2.4.6. IA stability in matrices
The stability of IA-spiked matrices was determined after 48 h of
storage at ambient temperature. The stability of these solutions
was studied by performing the analysis and observing any change
in the chromatographic pattern, compared with freshly prepared
solutions.
2.4.7. System suitability
The system suitability test was also carried out to evaluate the
adequacy of the system for the analysis. The parameters measured
were peak area, retention time, theoretical plates, tailing factor,
and resolution between DAID, GLY, and GEN.
2.5. Method application
The determination of DAID, GLY, and GEN in SAE and IAF were
performed as described in sections 2.3.2.1 and 2.3.2.2, respectively.
The IA determination in NEIAF and H-NEIAF was carried out as
described in section 2.3.2.3.
The permeation/retention studies for IA were evaluated using
Franz type diffusion cells, which presented a surface area for
diffusion of 1.77 cm2 and a receptor volume of 10.0 mL. The
excised circular porcine ear skin and esophageal mucosa, prepared
as described in section 2.3.2.4, were previously dipped in PBS pH
7.4 solution during 30 min. Then, they were mounted in a Franz-
type diffusion cell between the donor and receptor compartments,
with the inner part facing the upper inside portion of the cell. The
bathing solution was kept under a controlled temperature
(3271.0 1C) and stirred at 650 rpm. About 400 μL of NEIAF were
placed in the donor compartment, maintaining the sink conditions
for the assay. At the end of experiment (8 h), an aliquot of RF was
withdrawn for analysis and the skin or mucosa was removed from
the cell and cleaned using a cotton swab. Next, the skin layers and
mucosa were treated as described in section 2.3.2.4 to extract the
IA, and analyzed by the UFLC method.
3. Results and discussion
3.1. UFLC method development and advantages
For optimization studies of pharmaceutical formulations and
permeation assays through skin or mucosa, numerous samples
must be analyzed during the tests. Consequently, it is often
necessary to develop an easy, fast, and reliable method to quantify
the compounds of interest.
The UFLC was chosen in this study to achieve IA separation
with good resolution in a short time. The choice of an appropriate
column and other factors were evaluated considering the main
chromatographic parameters obtained for the major compounds
present in the SAE, since this sample was the most complex matrix
used in the present work (Table 1). The greatest IA separation,
with high resolution between all peaks, was achieved with a C18
column packed with 2.2 μm particle size. To allow a rapid and
satisfactory separation of the main products, the use of solvent
gradient, high temperature, and gradient of ﬂow rates was needed.
As previously reported by our research group, higher temperatures
is a useful tool for reducing analysis time since mobile phase
viscosity is signiﬁcantly reduced and this, in turn, decreases the
pressure and peak width [27]. The most effective separation
occurred with a gradient of 0.1% (v/v) triﬂuoroacetic acid in water
and acetonitrile. UV detection was at 260 nm, since all IA have
good absorption at this wavelength.
The soybean extract was submitted to acid hydrolysis because
isoﬂavone glycosides are the predominant forms in soybeans, but
the activities and higher skin permeation are mainly credited to
the aglycone forms [34,7]. However, when soy derivative products
such as foods or extracts are submitted to acid conditions, other
compounds could be obtained. For instance, the presence of sugars
under extreme pH conditions and high temperatures usually
induce the Maillard reaction, or caramelization process. Both
phenomena can result in the production of furanic aldehydes,
such as hydroxymethylfurfural (HMF) and furfural [35]. Recently,
our research group had isolated HMF and ethoxymethylfurfural
(EMF) from soybeans after acid hydrolysis in an ethanolic media
[36]. These compounds are reported as toxic [37,38], and for this
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reason, the puriﬁcation of acid extracts becomes essential before
they can be used in pharmaceutical products. Consequently, the
development of an analytical method that enables IA quantiﬁca-
tion and the detection of HMF and EMF comes to be necessary to
make sure these toxic compounds are removed from the extract.
In this way, the UFLC method proved to be capable of separating
the toxic compounds from the IA and is, therefore, suitable for the
quality control of the puriﬁcation processes.
In addition, to demonstrate the advantage of time-related
analysis and reduced solvent consumption, the SAE was analyzed
by the UFLC method and an HPLC method recently reported by our
research group [27]. The representative chromatographic separa-
tions for both methods are shown in Fig. 1. As can be observed, the
UFLC method greatly shortens the analysis time by up to three
times that of the HPLC method, while maintaining the resolution
between all peaks. Moreover, it is important to highlight that the
Table 1
Chemical structure for the main products obtained after acid hydrolysis of soybeans, as well as their UFLC retention times, UFLC peak parameters, maximum UV absorption (λ
max), and molecular ion [MþH]þ acquired by MS analysis.
Compound Chemical structure Retention time Theoretical plates Tailing factor Resolution λ (max) [Mþ1]þ
HMF 0.92 10046.42 2.03 - 229/282 127
EMF 2.87 14104.95 1.38 17.86 229/281 155
Daidzein 3.63 21105.32 1.27 8.93 248/301 255
Glycitein 4.07 32900.98 1.14 4.98 256/319 285
Genistein 5.05 63837.17 1.13 11.5 260 271
HMF: hydroxymethylfurfural; EMF: ethoxymethylfurfural.
Fig. 1. Representative chromatographic proﬁles of soybean acid extract obtained by (a) HPLC and (b) UFLC methods at 260 nm. Where (10) HMF, (20) EMF, (1) DAID, (2) GLY,
and (3) GEN.
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environmental impact and cost are minimized, since the UFLC ﬂow
rate was 0.5 mL min1, half that of the HPLC value.
Comparing the UFLC method described herein with other ultra-
fast methods reported in the literature, it is possible to observe
that the total run time is a little longer than the methods reported
by Kiss et al. [24] and Fiechter et al. [21], which showed the IA
analysis in soybeans and phytoestrogen-rich plants with chroma-
tographic time of under 5 min. However, it is important to note
that the separation of HMF, EMF, DAID, GLY, and GEN with high
resolution was herein achieved, even with the difference in
polarity between the furfural compounds and isoﬂavones.
3.2. UFLC method validation
3.2.1. Assessment of the matrix effect
Method validation is the process by which the compounds of
interest are reliably quantiﬁed independently of the matrix [31].
For this reason, during the development of an analytical and
bioanalytical method, it is essential to consider the effect of all
matrices involved, which can be easily detected by comparing the
response obtained from a standard solution with that from a
spiked pre-treated sample [27]. When the response range is
between -20%oME% o20%, the matrix effects is deemed low;
when it is between 50%oME% o-20% or 20%4 ME%450%, it is
considered medium, and when it is between ME%o50% or ME%
450%, it is considered high [39].
The matrix effects for each IA present in the SAE, IAF, NEIAF,
H- NEIAF, P. E/D skin layer, P. SC layer after tape stripping process,
RF and P. EM, were expressed by ME% and are presented in Table 2.
The data indicate that samples exhibited low matrix effects (ME%
o12.42) for isoﬂavones determination, when analyzed according
to Niessen et al. [39]. Furthermore, when IA spiked-matrices were
analyzed by UPLC-MS/MS, no interfering signals (m/z) were found
in the same retention time of DAID, GLY, and GEN. Therefore, the
proposed method dispenses with the need for clean-up pre-
treatment of the samples and is classiﬁed as a fast and simple
method for analyzing IA in complex matrices.
3.2.2. Speciﬁcity
The chromatographic separation of IA standards at 260 nm is
shown in Fig. 2A. The retention times for DAID, GLY, and GEN
peaks were 3.60, 4.07, and 5.05 min, with characteristic λmax
(maximum UV absorption) at 248/301, 256/319 and 260 nm
(Fig. 2B), and MS/MS spectra with characteristic molecular
[MþH]þ ions m/z 255 for DAI, m/z 285 for GLY, and m/z 271 for
GEN (Fig. 2C). The main fragmentation ions were in accordance
with those reported by Wu et al. [28], in which the characteristic
retro-Diels-Alder fragments m/z 137 for DAID, m/z 167 for GLY,
and m/z 153 for GEN were signiﬁcantly present.
The UFLC method speciﬁcity was assessed by injecting blank
matrices and evaluating the peak purity of each IA spiked-matrix.
No matrix-related interference was found, showing that the IA
peaks were free from any co-eluting substance and demonstrating
that the proposed method is speciﬁc for the simultaneous analysis
of IA in all of the assessed matrices (Fig. 3A).
Moreover, forced degradations were done to provide stability-
indicating properties. A stability-indicating method is deﬁned as
an analytical method that accurately quantiﬁes the compounds of
interest without interference from degradation products. In the
present work, the IA standards were submitted to acidic, alkaline,
neutral, oxidative, and thermal stress conditions. No signiﬁcant
changes were observed in the isoﬂavones after stress exposure in
acid, oxidative or neutral conditions at 25 1C and 60 1C during 6 h
of exposure. On the other hand, when the IA were submitted to the
Table 2
Linearity data of the isoﬂavone aglycone standards and the matrix effect for each matrix studied.
Matrix Compound Equation R2 LOD LOQ ME (%)
lg mL1
Standards Daid y¼19866x-337.73 0.999 0.10 0.35 
Gly y¼ 21752xþ142.0 0.999 0.09 0.32 
Gen y¼36619xþ355.32 0.999 0.10 0.32
SAE Daid y¼ 20071x-325.95 0.998 0.08 0.28 1.02
Gly y¼ 22006x-624.98 0.998 0.09 0.32 1.15
Gen y¼ 37002x-298.39 0.998 0.08 0.28 1.04
IAF Daid y¼ 19486xþ2760.6 0.993 0.17 0.57 1.95
Gly y¼ 21953xþ104.11 0.988 0.21 0.71 0.92
Gen y¼ 36988xþ3127.8 0.996 0.12 0.38 1.00
Daid y¼ 19389x-195.21 0.993 0.17 0.58 2.40
NEB Gly y¼ 21567x-119.18 0.995 0.13 0.45 0.85
Gen y¼ 35753xþ1182.1 0.994 0.15 0.50 2.36
H-NEB Daid y¼ 19722x-106.42 0.998 0.08 0.27 0.73
Gly y¼ 21986x-177.26 0.998 0.08 0.26 1.06
Gen y¼ 36700xþ181.32 0.998 0.08 0.28 0.22
P. E/D Daid y¼ 20003x-312.91 0.998 0.09 0.31 0.68
Gly y¼ 22079xþ54.060 0.998 0.08 0.26 1.48
Gen y¼ 36669xþ576.41 0.998 0.10 0.32 0.14
P. SC Daid y¼ 19709x-1007.9 0.995 0.14 0.48 -0.80
Gly y¼ 21605-640.460 0.995 0.13 0.44 -0.68
Gen y¼ 37172x-2245.4 0.998 0.09 0.32 1.49
P. EM Daid y¼ 19722x-24.812 0.998 0.10 0.33 0.72
Gly y¼ 21886xþ144.67 0.997 0.10 0.33 -0.62
Gen y¼ 36757þ939.10 0.997 0.10 0.33 -0.38
RF Daid y¼ 22682x-489.67 0.998 0.08 0.28 12.42
Gly y¼ 23718xþ44.349 0.998 0.09 0.30 8.29
Gen y¼ 39345x-988.07 0.999 0.09 0.39 6.93
SAE: soybean acid extract; IAF: isoﬂavone aglycone-rich fraction; NEB: blank nanoemulsion; H-NEB: hydrogel containing NEB; P. E/D: porcine epidermis/dermis; P. SC:
porcine stratum corneum after tape stripping process; P. EM: porcine esophageal mucosa; RF: receptor ﬂuid; R2¼determination coefﬁcient; LOD¼ limit of detection;
LOQ¼ limit of quantitation; ME: matrix effect.
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alkaline condition at 60 1C for 6 h (Fig. 3B), DAID degraded more
than 50%, GEN more than 20%, and GLY more than 15%.
However, only the degradation products of DAID and GEN
could be observed in the developed UFLC method. To enhance
the knowledge about the possible degraded products and conﬁrm
the purity of the isoﬂavones, the peaks were analyzed by PDA and
MS detector following the stress process. The degradation pro-
ducts D1, D2, D3, D4, D5, and D6 had retention times of 1.80, 4.33,
4.63, 4.75, 5.29, and 5.75 min, respectively. In addition, they were
well separated from the other ones in the chromatographic
system, resulting in a good resolution (41.4 between all peaks).
Evaluation of DAID, GLY, and GEN purity after the stress condition
demonstrated that these peaks were free from any co-eluting
substance. The maximum UV spectra of the main degraded peaks
showed λmax: 255 nm for D1, λmax: 236/289 nm for D2, λmax:
230/277 nm for D3, λmax: 240/283 nm for D4, λmax: 260/290/
322 nm for D5, and λmax: 260/318 nm for D6. Furthermore, the
MS spectra of three out of six degradation products were com-
pared with the literature data, and the results showed that D1, D2,
and D3 have the same precursor ions [MþH]þ , m/z 255, 259, and
273, than the degradation products reported by Yatsu et al. [27].
However, more studies are needed on the other three degradation
products to propose their identities.
3.2.3. Linearity, precision, and accuracy
The results for linearity are shown in Table 2. Analysis of the
determination coefﬁcients demonstrated that the method is linear
for all of the standard compounds within the tested range. The
conﬁdence interval observed in the t-test on the intercepts and the
graphic examination of the residuals also demonstrated the
absence of constant systematic errors (data not shown).
The LOD and LOQ calculated by standard curves are also presented
in Table 2. The lower LOQ (LLOQ) measurement is a great concern in
the validationmethods, which are used to quantify low concentrations
of drugs in biological matrices. The LLOQ was ﬁxed at 0.1 mgmL1 for
all isoﬂavones in all assessed matrices, since it was the lowest IA
concentration that could be determined with acceptable precision and
accuracy (RSDo15%).
The precision and accuracy of post-extraction spiked-matrices
were evaluated by analyzing the IA at concentrations of
0.1 mg mL1 (lowest concentration), 2.0 mg mL1 (medium con-
centration), and 4.0 mg mL1 (highest concentration) for each
sample. The intra-day precision data for IA showed a relative
standard deviation (RSD) value between 0.04–3.96 for the analy-
tical assays (NE, H-NE, RF), between 0.02–8.40 for the bioanalytical
assays (P.SC, P. E/D, P. EM), and between 0.09–6.21 for the
biotechnological products (SEA, IAF). The inter-day precision data
for IA showed a RSD value between 0.17–5.12 for the analytical
assays, between 0.66–8.00 for the bioanalytical assays, and
between 0.96–10.70 for the biotechnological products. The accu-
racy results for IA in all matrices were within the 90.37% to
104.81% range. Despite the complexity of the different matrices,
the UFLC method can be considered precise and accurate accord-
ing to ofﬁcial guidelines.
3.2.4. Robustness
A model's robustness refers to its ability to remain unaffected
by small, deliberate variations in the analysis conditions [33].
A multivariate approach using design of experiments is often
recommended in robustness testing since a number of different
factors can be analyzed concurrently with a reduced number of
experiments [40].
The responses after assessing the Plackett-Burman design are
the percentage of DAID, GLY, and GEN in the samples in relation to
the standard solutions in each experiment. As shown in Fig. 4, no
signiﬁcant factors were revealed for all analyses as the calculated
t-values were lower than the t-critical values (α¼0.05). Thus, there
were no signiﬁcant changes in the assay results in terms of the
percentage of IA contents with the changes made in the experi-
mental conditions, thereby demonstrating the proposed method's
robustness.
Fig. 2. Analysis of isoﬂavones (1) DAID, (2) GLY, and (3) GEN by (a) UFLC method, (b) UV–vis absorption spectra; (c) MS/MS spectra measured in positive mode.
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3.2.5. IA stability in matrices
The stability evaluation results showed that the concentration
of isoﬂavones in the different matrices remained constant after
48 h of storage at room temperature. The DAID, GLY, and GEN
amounts in all matrices after this period of time were found to be
between 99.45% and 101.99%.
3.2.6. IA extraction from skin and mucosa
The recovery data for IA quantiﬁcation after extraction of
previously spiked-matrices are shown in Table 3, and was within
FDA recommendations for bioanalytical method validation [30].
Taken together, the recovery yields are highly satisfactory and
demonstrated that 30 min was sufﬁcient for the complete IA
extraction from matrices, and no matrix components interfered
during the procedure. Furthermore, IA recovery showed adequate
precision in all assessed matrices (RSDo8.3%).
3.2.7. System suitability
Routine analyses of the standard substances were performed
under the developed experimental conditions. Parameter values
and their variability (RSD, %) for each compound were: (i) DAID
analysis: 3.6 (0.13) min for migration time, 20166 (2.11) for
theoretical plates, and 1.28 (0.40) for tailing factor; (ii) GLY
analysis: 4.07 (0.09) min for migration time, theoretical plates
32122 (1.95), and tailing factor 1.23 (0.81); (iii) GEN analysis: 5.05
(0.09) min for migration time, 60526 (2.06) for theoretical plates,
and 1.16 (0.74) for tailing factor. The resolution between DAID and
GLY peaks was 4.9 (0.99) and 11.39 (0.85) between GLY and GEN.
The parameters indicate that the system is suitable for the
analysis.
3.3. Method application
As a last objective of this work, the UFLC method was applied to
determine the IA amount in the real samples. The IA content in SAE,
Fig. 3. Representative chromatographic proﬁles obtained in the speciﬁcity assay for the (a) different matrices, where, IAF: isoﬂavone aglycone-rich fraction, 1: DAID, 2: GLY,
3: GEN, NEB: blank nanoemulsions, H-NEB: topical hydrogel containing nanoemulsions, P. SC: porcine stratum corneum after tape stripping method, P. E/D: porcine
epidermis/dermis skin layer, P. EM: porcine esophageal mucosa, RF: receptor ﬂuid; and for the (b) degradation products of DAID (D1, D2, D3, D4), and GEN (D5, D6) obtained
after alkaline hydrolysis of separated standard solutions of DAID and GEN.
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IAF, NEIAF, H-NEIAF, receptor ﬂuid, and in skin or mucosa layers are
shown in Table 4, and the results indicate the precision of the
method in all samples, in which the RSD was lower than 3.14% in the
analytical assays and lower than 18.52% in the bioanalytical assays.
As previously reported by Yatsu et al. [27], the soybean cultivar
used in this work had a total isoﬂavone aglycones content greater
that had been reported for 14 different soybeans cultivars [21],
demonstrating the importance of this sample for industrial
Fig. 4. Bar charts representing the t-calculated for quantitative determination (assay) of the investigated factors (1,2,3, and 4) in Plackett-Burman experimental design and
their t-critical, represented by the vertical line, for each isoﬂavone in the matrices. Where, 1: column oven temperature, 2: initial ﬂow rate, 3: TFA concentration, 4: initial
organic composition, SAE: soybean acid extract, IAF: isoﬂavone aglycone-rich fraction, NEIAF isoﬂavone aglycone rich-fraction loaded nanoemulsion, H-NEIAF topical hydrogel
containing nanoemulsions, P. SC: porcine stratum corneum layer after tape stripping method, P. E/D: porcine epidermis/dermis skin layer, P. EM: porcine esophageal mucosa,
RF: receptor ﬂuid and the bar charts: DAID (black columns), GLY (gray columns), and GEN (white columns).
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applications. To obtain the IA in a pure fraction, we described an
appropriate method of puriﬁcation and acquisition of DAID, GLY, and
GEN from SAE, which allowed obtaining a fraction with 0.89 mg of IA
per mg of powder (Table 4) and free from HMF and EMF (Fig. 3A IAF).
When this fraction was incorporated into nanoemulsions, the
quantiﬁcation of all IA showed adequate repeatability. This also
occurred during the analysis of hydrogels containing the NEIAF.
Both formulations had successfully incorporated the IA, since their
amount was 0.86 mg mL1, resulting in more than 96% of IA when
compared with the 0.89 mg mL1 initially added.
Regarding the in vitro skin permeation/retention study, no IA
could be detected in the receptor ﬂuid after 8 h of assay. Con-
versely, DAID and GEN could be quantiﬁed with adequate preci-
sion in the stratum corneum, as well as in the epidermis and
dermis layers. Yet, the same was not observed with GLY, which
was detected in all skin layers, but could not be quantiﬁed,
because its peak areas were always lower than the LLOQ.
In the literature, no report was found concerning the validation
of a method for simultaneous quantiﬁcation of DAID, GLY, and GEN
after skin permeation/retention assays. Among some studies com-
prising such matters, Vargas et al. [11] showed GEN quantiﬁcation in
the skin layers and receptor ﬂuid after the cutaneous permeation/
retention assay using a previously validated HPLC method [12]. On
the other hand, for simultaneous IA quantiﬁcation, Huang et al. [6]
have reported in vitro and in vivo skin retention/permeation of DAID
and GEN, without demonstrating the validation of the method used
for the assessment. That being said, the present study reports, for
the ﬁrst time, a fast and validated method for skin studies involving
all soybean isoﬂavone aglycones.
In addition, the method was able to quantify IA in a mucosa
permeation assay in both receptor ﬂuid and tissue with satisfac-
tory precision. This is an important ﬁnding, considering that
isoﬂavone aglycones have shown anti-herpetic activities [4],
requiring application on some mucosas to carry out their func-
tions. The choice of porcine esophageal mucosa to investigate the
permeation study was done in accordance with Consuelo et al.
[41], since the authors showed that this membrane is a useful and
practical substitute for buccal mucosa for in vitro permeability
studies. Lastly, it is important to emphasize that this was the ﬁrst
time this application had been reported for isoﬂavone aglycones.
4. Conclusions
The overall results showed that the developed UFLC method is
an excellent tool for determing isoﬂavone aglycones present in
soybean acid extract, isoﬂavone aglycone-rich fractions, isoﬂavone
aglycones loaded-nanoemulsions, topical hydrogel containing iso-
ﬂavone aglycones loaded-nanoemulsions, porcine skin layers,
porcine esophageal mucosa, and in a 30% ethanol solution in
phosphate buffer pH 7.4 (receptor ﬂuid for permeation studies).
The method had a low matrix effect, without any interference
from the matrices and degradation products, besides being simple,
Table 3
Recovery data of the IA added in biological matrices.
Matrix Nominal (lg mL1) Recovery (%) (RSD)
DAID GLY GEN
P. E/D skin layer 0.1 98.09 (8.3) 95.12 (3.7) 95.43 (5.2)
2 97.94 (1.4) 99.45 (2.0) 99.93 (1.1)
4 95.15 (2.8) 94.56 (2.3) 100.8 (8.1)
P. SC skin layer 0.1 101.8 (2.6) 99.60 (5.9) 99.80 (4.2)
2 101.1 (1.6) 99.10 (1.8) 100.9 (2.6)
4 101.8 (1.5) 100.0 (1.3) 102.0 (5.7)
P. E mucosa 0.1 98.81 (1.6) 97.92 (3.2) 99.13 (1.5)
2 99.16 (2.3) 93.49 (3.1) 93.24 (0.3)
4 98.24 (2.2) 95.49 (2.3) 96.32 (1.4)
P. E/D: porcine epidermis/dermis; P. SC: porcine stratum corneum after tape stripping process; P. E: porcine esophageal mucosa; RSD¼relative
standard deviation.
Table 4
Determination of the isoﬂavone aglycones in real samples.
Application of UFLC method Mean of six replicates (RSD)
DAID GLY GEN IA Total
Samples
SAE (mg 100 g 1 of DSS) 75.14 (2.49) 16.54 (2.66) 112.16 (0.40) 203.85 (1.16)
IAF (mg mg 1) 0.45 (1.18) 0.043 (1.02) 0.39 (2.64) 0.89 (1.14)
NEIAF (mg mL 1) 0.44 (1.81) 0.037 (1.68) 0.37 (3.14) 0.86 (2.39)
H-NEIAF (mg g 1) 0.45 (1.40) 0.038 (1.18) 0.37 (1.47) 0.86 (1.42)
Skin retention
P. SC (mg cm2 1) 0.47 (13.50) LLQ 0.16 (16.25) 0.63 (14.87)
P.E/D (mg cm2 1) 0.24 (18.52) LLQ 0.39 (14.50) 0.63 (16.50)
RF (mg cm2 1) LLQ LLQ LLQ 
Mucosa permeation
P.E mucosa (mg cm2 1) 2.70 (10.16) 0.29 (11.44) 3.43 (10.78) 6.42 (10.80)
RF (mg cm2 1) 6.65 (9.87) 0.79 (18.02) 4.25 (18.10) 11.69 (15.30)
SAE: soybean acid extract; DSS: defatted soybean seeds; IAF: isoﬂavone aglycone-rich fraction; NEIAF: isoﬂavone aglycone rich-fraction loaded nanoemulsion; H-NEIAF:
hydrogel containing isoﬂavone aglycone rich-fraction loaded nanoemulsion; P. E/D: porcine epidermis/dermis; P. SC: porcine stratum corneum after tape stripping process;
RF: receptor ﬂuid; LLQ: lower than limit of quantiﬁcation; P. E: porcine esophageal mucosa;; RSD¼relative standard deviation.
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quick, and able to quantify isoﬂavones with precision, robustness,
and accuracy in different complex matrices.
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